Swedish Orphan Biovitrum AB (SOBIV)

174.15
-52.45(-23.15%)
  • Volume:
    9,832,459
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    168.80 - 177.60
  • Type:Equity
  • Market:Sweden
  • ISIN:SE0000872095
  • S/N:307114495

SOBIV Overview

Prev. Close
226.6
Day's Range
168.8-177.6
Revenue
15.21B
Open
170.2
52 wk Range
127.1-245.4
EPS
9.85
Volume
9,832,459
Market Cap
51.28B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
719,112
P/E Ratio
23.00
Beta
0.63
1-Year Change
37.21%
Shares Outstanding
295,144,629
Next Earnings Date
10 Feb 2022
What is your sentiment on Swedish Orphan Biovitrum AB?
or
Vote to see community's results!

Swedish Orphan Biovitrum AB Company Profile

Employees
1532
Market
Sweden

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, Ammonul, Betapred, Caphosol, Fibclot, IVheBex, and Willfact. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.